Contact Information: For further information contact: Scott Fraser Vice President, Marketing EndoChoice, Inc 11800 Wills Rd. Suite 100 Alpharetta, GA 30009 770-682-8700 (Office) Email:
ALPHARETTA, GA--(Marketwire - September 1, 2009) - EndoChoice, Inc., an emerging leader in GI
endoscopy products and services, announced today the appointment of Jim
Balkcom as its Chairman of the Board of Directors.
"We are very pleased to have a proven leader like Jim Balkcom join the
EndoChoice team as Chairman," said Mark Gilreath, founder and CEO. "Jim has
the unique combination of impressive entrepreneurial success as CEO, and
extensive board experience at small and large companies. He will be a
tremendous asset to EndoChoice."
Jim Balkcom draws upon more than 30 years of experience as a CEO and
Chairman of companies in multiple industries. As his career exemplifies,
Jim is a business leader with a demonstrated ability to drive
organizational success. He served as CEO of Techsonic Industries, the
developer of the state-of-the-art Liquid Crystal Depthsounders. After
selling and exiting Techsonic, he became CEO of Pameco, a $600 million
revenue distribution company. He has also served on the board of directors
and as Chairman at several commercial banks, distribution, and high-tech
companies. A native of Atlanta, Jim attended the Georgia Institute of
Technology, The United States Military Academy at West Point and has an MBA
in Finance from Harvard University. Mr. Balkcom currently serves as
Civilian Aid to the Secretary of The Army.
"EndoChoice has a unique opportunity to be an advocate for this underserved
market," said Balkcom. "This outstanding leadership team has demonstrated a
remarkable ability to execute by rapidly building this industry leading
organization."
About EndoChoice
Incorporated in 2007, EndoChoice is a specialty medtech company delivering
innovative solutions to professionals in gastrointestinal endoscopy. The
Company is led by a management team with executive experience from GI
companies such as Given Imaging, Boston Scientific, C.R. Bard and Pentax
Medical. The Company leverages its sales force and an efficient web-based
channel to deliver innovative products and services to professionals in the
field of gastrointestinal endoscopy in the USA, Europe and Asia. The
Company is headquartered in Alpharetta, Georgia. For more information,
visit www.endochoice.com.